Hexima Ltd - Strategic SWOT Analysis Review

November 2020 | 24 pages | ID: H307B73BA15EN
GlobalData

Abstracts

Hexima Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Hexima Ltd (Hexima) is a biotechnology company that researches, develops and commercializes plant-derived proteins and peptides for its applications as human therapeutics. The company utilizes its proprietary technologies such as plant defensin antifungal technology platform and peptide ligation technology for the development of products to find treatments for various fungal/infectious diseases. HXP124, its pipeline drug candidate is being developed for the treatment of fungal nail infections (onychomycosis). The company's operations are mainly in Australia. Hexima is headquartered in Melbourne, Victoria, Australia.

Hexima Ltd Key Recent Developments

May 21,2019: Hexima announces appointment of Michael Aldridge
Mar 12,2019: Hexima: Interim Consolidated Financial Report

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Hexima Ltd - Key Facts
Hexima Ltd - Key Employees
Hexima Ltd - Key Employee Biographies
Hexima Ltd - Major Products and Services
Hexima Ltd - History
Hexima Ltd - Company Statement
Hexima Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Hexima Ltd - Business Description
Hexima Ltd - SWOT Analysis
SWOT Analysis - Overview
Hexima Ltd - Strengths
Hexima Ltd - Weaknesses
Hexima Ltd - Opportunities
Hexima Ltd - Threats
Hexima Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Hexima Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 21, 2019: Hexima announces appointment of Michael Aldridge
Mar 12, 2019: Hexima: Interim Consolidated Financial Report

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Hexima Ltd, Key Facts
Hexima Ltd, Key Employees
Hexima Ltd, Key Employee Biographies
Hexima Ltd, Major Products and Services
Hexima Ltd, History
Hexima Ltd, Subsidiaries
Hexima Ltd, Key Competitors
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Hexima Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020